$100.0 Million
Ventyx Biosciences
Ventyx Biosciences
PIPE
Joint Placement Agent
$40.0 Million
Skye Bioscience
Skye Bioscience
PIPE
Sole Placement Agent
$50.0 Million
Unicycive
Unicycive Therapeutics
PIPE
Joint Placement Agent
$75.0 Million
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$600.0 Million
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$200.0 Million
Praxis Precision Medicines
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$100.0 Million
Boundless Bio, Inc.
Boundless Bio, Inc.
Initial Public Offering
Active Bookrunner
$42.0 Million
Trinitas
Trinitas Capital Management, LLC
Senior Unsecured Notes Offering
Sole Placement Agent
$73.3 Million
CereVasc
Bain
Xontogeny
CereVasc, Inc.
CereVasc, Inc. has received a Series B Financing from Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund (PXV)

Financial Advisor
$50.0 Million
Legion
Riverwood
Legion Technologies, Inc.
Legion Technologies, Inc. has received a growth investment from Riverwood Capital Management L.P.
Financial Advisor
Subscribe to Financing

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.